Novozymes A/S (OTCMKTS:NVZMY) Short Interest Down 55.6% in March

→ Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad)

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 1,600 shares, a decline of 55.6% from the March 15th total of 3,600 shares. Based on an average daily volume of 19,600 shares, the short-interest ratio is presently 0.1 days.

Novozymes A/S Stock Performance

NVZMY stock traded up $1.67 during midday trading on Thursday, reaching $55.88. 11,815 shares of the company's stock traded hands, compared to its average volume of 17,940. Novozymes A/S has a 52 week low of $38.75 and a 52 week high of $61.86. The company has a 50-day moving average price of $56.59 and a two-hundred day moving average price of $51.67. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.80 and a current ratio of 1.30. The firm has a market capitalization of $26.17 billion, a PE ratio of 35.37, a price-to-earnings-growth ratio of 3.85 and a beta of 0.82.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) last released its quarterly earnings data on Wednesday, January 31st. The biotechnology company reported $0.36 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.47 by ($0.11). Novozymes A/S had a net margin of 16.88% and a return on equity of 21.42%. The company had revenue of $664.46 million for the quarter. As a group, equities analysts anticipate that Novozymes A/S will post 1.93 EPS for the current year.


Novozymes A/S Cuts Dividend

The company also recently declared a dividend, which will be paid on Monday, May 20th. Stockholders of record on Thursday, May 2nd will be issued a $0.1853 dividend. The ex-dividend date is Wednesday, May 1st. Novozymes A/S's payout ratio is 24.05%.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

See Also

Should you invest $1,000 in Novozymes A/S right now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Featured Articles and Offers

Search Headlines: